[go: up one dir, main page]

DK1009425T3 - Anvendelse af latens-associeret-peptid til fremstilling af et medikament til forøgelse af sårheling - Google Patents

Anvendelse af latens-associeret-peptid til fremstilling af et medikament til forøgelse af sårheling

Info

Publication number
DK1009425T3
DK1009425T3 DK98903122T DK98903122T DK1009425T3 DK 1009425 T3 DK1009425 T3 DK 1009425T3 DK 98903122 T DK98903122 T DK 98903122T DK 98903122 T DK98903122 T DK 98903122T DK 1009425 T3 DK1009425 T3 DK 1009425T3
Authority
DK
Denmark
Prior art keywords
composition
medication
prepare
wound healing
latency associated
Prior art date
Application number
DK98903122T
Other languages
Danish (da)
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DK1009425T3 publication Critical patent/DK1009425T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DK98903122T 1997-02-13 1998-02-13 Anvendelse af latens-associeret-peptid til fremstilling af et medikament til forøgelse af sårheling DK1009425T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702943.3A GB9702943D0 (en) 1997-02-13 1997-02-13 Wound healing
PCT/GB1998/000316 WO1998035695A1 (fr) 1997-02-13 1998-02-13 Cicatrisation d'une blessure

Publications (1)

Publication Number Publication Date
DK1009425T3 true DK1009425T3 (da) 2002-10-14

Family

ID=10807557

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98903122T DK1009425T3 (da) 1997-02-13 1998-02-13 Anvendelse af latens-associeret-peptid til fremstilling af et medikament til forøgelse af sårheling

Country Status (12)

Country Link
US (1) US6319907B1 (fr)
EP (1) EP1009425B1 (fr)
JP (1) JP4307561B2 (fr)
AT (1) ATE223228T1 (fr)
AU (1) AU728851B2 (fr)
CA (1) CA2280873C (fr)
DE (1) DE69807710T2 (fr)
DK (1) DK1009425T3 (fr)
ES (1) ES2181165T3 (fr)
GB (1) GB9702943D0 (fr)
PT (1) PT1009425E (fr)
WO (1) WO1998035695A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756060B1 (en) * 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US6767891B2 (en) * 2000-06-14 2004-07-27 Chanda Zaveri Peptides with wound healing activity
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
ATE429925T1 (de) * 2000-07-31 2009-05-15 Univ Bar Ilan Methoden und pharmazeutische zusammensetzungen zur wundheilung
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
US20050164909A1 (en) * 2003-07-16 2005-07-28 The Ohio State University Research Foundation Methods and reagents for treating inflammation and fibrosis
WO2005013885A2 (fr) * 2003-08-07 2005-02-17 Healor Ltd. Compositions pharmaceutiques et methodes permettant d'accelerer la cicatrisation de plaies
WO2007026356A2 (fr) * 2005-08-29 2007-03-08 Healor Ltd. Methodes et compositions de prevention et de traitement de la peau diabetique et du vieillissement cutane
KR20150072458A (ko) 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
EP2653166A3 (fr) * 2007-07-30 2014-08-27 Healor Ltd. Composition pharmaceutique pour le traitement des plaies et procédés associés
CN101855235B (zh) * 2007-10-29 2013-04-24 赫里克斯生物医疗公司 保护性皮肤护理四肽
CA2710375A1 (fr) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Traitement des conditions orthopediques
EP2252690A2 (fr) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Utilisation de polynucléotides anti-connexine 43 pour le traitement de cicatrices anormales ou excessives
EP2234656A2 (fr) 2007-12-21 2010-10-06 Coda Therapeutics, Inc. Dispositifs médicaux améliorés
US20100172217A1 (en) * 2009-01-08 2010-07-08 Von Bezold Ernst System of Methods and Apparati for Handling and Modifying Information Energy and Matter by Formative Resonance
ES2601827T3 (es) * 2009-02-24 2017-02-16 Arava Bio-Tech Ltd. Agentes antagonistas de visfatina para el tratamiento del acné y de otras afecciones
WO2011083483A2 (fr) 2010-01-11 2011-07-14 Healor Ltd. Procédé pour traiter une maladie et un trouble inflammatoires
US9387183B2 (en) 2011-12-28 2016-07-12 Kuwait University Method of treating diabetes-related impaired wound healing
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
US10232009B1 (en) * 2017-09-29 2019-03-19 Pro Sunfun Biotech Research And Development Co., Ltd. Peptide for promoting wound healing, its composition and method of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2068204C (fr) * 1989-11-22 2002-02-12 Arthur Levinson Peptides associes a la latence et leur utilisation
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
AU5587094A (en) * 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
US6074840A (en) * 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
AU710153B2 (en) * 1994-03-29 1999-09-16 Renovo Limited Wound healing

Also Published As

Publication number Publication date
ATE223228T1 (de) 2002-09-15
AU728851B2 (en) 2001-01-18
US6319907B1 (en) 2001-11-20
CA2280873C (fr) 2010-04-06
AU5995398A (en) 1998-09-08
DE69807710T2 (de) 2003-06-05
DE69807710D1 (de) 2002-10-10
PT1009425E (pt) 2002-11-29
CA2280873A1 (fr) 1998-08-20
HK1025504A1 (en) 2000-11-17
EP1009425A1 (fr) 2000-06-21
JP2001511797A (ja) 2001-08-14
JP4307561B2 (ja) 2009-08-05
GB9702943D0 (en) 1997-04-02
WO1998035695A1 (fr) 1998-08-20
EP1009425B1 (fr) 2002-09-04
ES2181165T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
ATE182792T1 (de) Wundheilung
DK1009425T3 (da) Anvendelse af latens-associeret-peptid til fremstilling af et medikament til forøgelse af sårheling
Aköz et al. Combination of different techniques for the treatment of earlobe keloids
HRP20010119B1 (hr) Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
WO2001041707A3 (fr) Modulation in vivo des niveaux de glutamine et de glycine dans le traitement de l'autisme
WO2001007067A3 (fr) Solutions et procedes permettant d'inhiber la douleur, les inflammations et la degradation des cartilages
PT1223980E (pt) Utilizacao de inibidores de csf-1
NZ518608A (en) Local prevention or amelioration of pain from surgically closed wounds
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
WO2002053101A3 (fr) Procede de traitement de troubles fibrogenes et autres symptomes de type ivc
DE50014532D1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
CA2156481A1 (fr) Compositions antagonistes du recepteur 5-ht2, utiles pour le traitement des troubles veineux
SE9101840L (sv) Ny medicinsk anvaendning
SE9902597D0 (sv) New use
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
WO2000059940A3 (fr) Gene et proteine lies au facteur de croissance d'origine plaquettaire
CZ223199A3 (cs) Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
WO1997026880A3 (fr) Utilisation d'une combinaison de delavirdine et d'un ou plusieurs inhibiteurs de protease chez des patients contamines par le vih-1
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
CN115414524A (zh) 重组人ⅲ型胶原蛋白水凝胶敷料在防治烧伤瘢痕中的应用